Figure 3.
Kaplan Meier curve describing survival of PAH patients with decrease in SV/ESV (n= 13) or stable/increased SV/ESV (n=31) at follow up.
Kaplan Meier curve describing survival of PAH patients with decrease in SV/ESV (n= 13) or stable/increased SV/ESV (n=31) at follow up.